{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T04:06:03Z","timestamp":1789099563272,"version":"build-2803163510"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":86,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-026-05445-8","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T16:34:14Z","timestamp":1781714054000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Steroidogenesis is associated with bladder cancer progression via reprogramming the metabolic landscape of the tumor immune microenvironment"],"prefix":"10.1007","volume":"17","author":[{"given":"Lei","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huachi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,17]]},"reference":[{"issue":"3","key":"5445_CR1","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.eururo.2018.04.029","volume":"74","author":"V Panebianco","year":"2018","unstructured":"Panebianco V, Narumi Y, Altun E, Bochner BH, Efstathiou JA, Hafeez S, Huddart R, Kennish S, Lerner S, Montironi R, et al. Multiparametric Magnetic Resonance Imaging for Bladder Cancer: Development of VI-RADS (Vesical Imaging-Reporting And Data System). Eur Urol. 2018;74(3):294\u2013306.","journal-title":"Eur Urol"},{"issue":"2","key":"5445_CR2","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.eururo.2023.03.029","volume":"84","author":"I Jubber","year":"2023","unstructured":"Jubber I, Ong S, Bukavina L, Black PC, Comp\u00e9rat E, Kamat AM, Kiemeney L, Lawrentschuk N, Lerner SP, Meeks JJ, et al. Epidemiology of Bladder Cancer in 2023: A Systematic Review of Risk Factors. Eur Urol. 2023;84(2):176\u201390.","journal-title":"Eur Urol"},{"issue":"10","key":"5445_CR3","first-page":"e95675","volume":"17","author":"KA John","year":"2025","unstructured":"John KA, Odibo AO, Soliman AM, Abayomi M, Awah FM, Barrah VU. The Future of Bladder Cancer Therapies: Integrating Hydrogel Scaffolds for Epigenetic Regulator Delivery. Cureus. 2025;17(10):e95675.","journal-title":"Cureus"},{"key":"5445_CR4","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.cancergen.2024.06.002","volume":"286\u2013287","author":"D Sonkin","year":"2024","unstructured":"Sonkin D, Thomas A, Teicher BA. Cancer treatments: Past, present, and future. Cancer Genet. 2024;286\u2013287:18\u201324.","journal-title":"Cancer Genet"},{"issue":"19","key":"5445_CR5","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1001\/jama.2020.17598","volume":"324","author":"AT Lenis","year":"2020","unstructured":"Lenis AT, Lec PM, Chamie K, Mshs MD. Bladder Cancer: A Review. JAMA. 2020;324(19):1980\u201391.","journal-title":"JAMA"},{"key":"5445_CR6","doi-asserted-by":"publisher","first-page":"102530","DOI":"10.1016\/j.ctrv.2023.102530","volume":"115","author":"CM Ascione","year":"2023","unstructured":"Ascione CM, Napolitano F, Esposito D, Servetto A, Belli S, Santaniello A, Scagliarini S, Crocetto F, Bianco R, Formisano L. Role of FGFR3 in bladder cancer: Treatment landscape and future challenges. Cancer Treat Rev. 2023;115:102530.","journal-title":"Cancer Treat Rev"},{"issue":"12","key":"5445_CR7","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1158\/0008-5472.CAN-24-3217","volume":"85","author":"Y Yu","year":"2025","unstructured":"Yu Y, Gao X, Zhao H, Sun J, Wang M, Xiong X, Li J, Huang C, Zhang H, Jiang G, et al. A Genome-Wide Synthetic Lethal Screen Identifies Spermidine Synthase as a Target to Enhance Erdafitinib Efficacy in FGFR-Mutant Bladder Cancer. Cancer Res. 2025;85(12):2288\u2013301.","journal-title":"Cancer Res"},{"issue":"12","key":"5445_CR8","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s13238-021-00846-7","volume":"13","author":"L Sun","year":"2022","unstructured":"Sun L, Zhang H, Gao P. Metabolic reprogramming and epigenetic modifications on the path to cancer. Protein Cell. 2022;13(12):877\u2013919.","journal-title":"Protein Cell"},{"issue":"1","key":"5445_CR9","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan D. Hallmarks of Cancer: New Dimensions. Cancer Discov. 2022;12(1):31\u201346.","journal-title":"Cancer Discov"},{"issue":"5","key":"5445_CR10","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.7150\/ijbs.77979","volume":"19","author":"C Zhou","year":"2023","unstructured":"Zhou C, Yu T, Zhu R, Lu J, Ouyang X, Zhang Z, Chen Q, Li J, Cui J, Jiang F, et al. Timosaponin AIII promotes non-small-cell lung cancer ferroptosis through targeting and facilitating HSP90 mediated GPX4 ubiquitination and degradation. Int J Biol Sci. 2023;19(5):1471\u201389.","journal-title":"Int J Biol Sci"},{"key":"5445_CR11","doi-asserted-by":"publisher","first-page":"1196523","DOI":"10.3389\/fendo.2023.1196523","volume":"14","author":"VT Fabris","year":"2023","unstructured":"Fabris VT, Spring L, Helguero LA. Editorial: Steroid hormone receptors and cell cycle in breast cancer. Front Endocrinol (Lausanne). 2023;14:1196523.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"5445_CR12","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.cmet.2019.04.002","volume":"30","author":"X Ma","year":"2019","unstructured":"Ma X, Bi E, Lu Y, Su P, Huang C, Liu L, Wang Q, Yang M, Kalady MF, Qian J, et al. Cholesterol Induces CD8(+) T Cell Exhaustion in the Tumor Microenvironment. Cell Metab. 2019;30(1):143\u2013e156145.","journal-title":"Cell Metab"},{"issue":"4","key":"5445_CR13","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.ccell.2024.02.002","volume":"42","author":"H Zheng","year":"2024","unstructured":"Zheng H, An M, Luo Y, Diao X, Zhong W, Pang M, Lin Y, Chen J, Li Y, Kong Y, et al. PDGFR\u03b1(+)ITGA11(+) fibroblasts foster early-stage cancer lymphovascular invasion and lymphatic metastasis via ITGA11-SELE interplay. Cancer Cell. 2024;42(4):682\u2013e700612.","journal-title":"Cancer Cell"},{"issue":"12","key":"5445_CR14","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","volume":"16","author":"I Korsunsky","year":"2019","unstructured":"Korsunsky I, Millard N, Fan J, Slowikowski K, Zhang F, Wei K, Baglaenko Y, Brenner M, Loh PR, Raychaudhuri S. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat Methods. 2019;16(12):1289\u201396.","journal-title":"Nat Methods"},{"issue":"16","key":"5445_CR15","doi-asserted-by":"publisher","first-page":"2660","DOI":"10.1200\/JCO.2009.25.0977","volume":"28","author":"JS Lee","year":"2010","unstructured":"Lee JS, Leem SH, Lee SY, Kim SC, Park ES, Kim SB, Kim SK, Kim YJ, Kim WJ, Chu IS. Expression signature of E2F1 and its associated genes predict superficial to invasive progression of bladder tumors. J Clin Oncol. 2010;28(16):2660\u20137.","journal-title":"J Clin Oncol"},{"issue":"1","key":"5445_CR16","doi-asserted-by":"publisher","first-page":"34","DOI":"10.7150\/jca.100922","volume":"16","author":"H Liu","year":"2025","unstructured":"Liu H, Li Y, Karsidag M, Tu T, Wang P. Technical and Biological Biases in Bulk Transcriptomic Data Mining for Cancer Research. J Cancer. 2025;16(1):34\u201343.","journal-title":"J Cancer"},{"key":"5445_CR17","doi-asserted-by":"publisher","first-page":"102042","DOI":"10.1016\/j.genrep.2024.102042","volume":"37","author":"H Liu","year":"2024","unstructured":"Liu H, Guo Z, Wang P. Genetic expression in cancer research: Challenges and complexity. Gene Rep. 2024;37:102042.","journal-title":"Gene Rep"},{"issue":"7","key":"5445_CR18","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W. Smyth GK: limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47.","journal-title":"Nucleic Acids Res"},{"key":"5445_CR19","doi-asserted-by":"publisher","first-page":"105439","DOI":"10.1016\/j.jsbmb.2019.105439","volume":"194","author":"L Schiffer","year":"2019","unstructured":"Schiffer L, Barnard L, Baranowski ES, Gilligan LC, Taylor AE, Arlt W, Shackleton CHL, Storbeck KH. Human steroid biosynthesis, metabolism and excretion are differentially reflected by serum and urine steroid metabolomes: A comprehensive review. J Steroid Biochem Mol Biol. 2019;194:105439.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"W1","key":"5445_CR20","doi-asserted-by":"publisher","first-page":"W509","DOI":"10.1093\/nar\/gkaa407","volume":"48","author":"T Li","year":"2020","unstructured":"Li T, Fu J, Zeng Z, Cohen D, Li J, Chen Q, Li B, Liu XS. TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res. 2020;48(W1):W509\u201314.","journal-title":"Nucleic Acids Res"},{"key":"5445_CR21","doi-asserted-by":"publisher","first-page":"1354940","DOI":"10.3389\/fonc.2024.1354940","volume":"14","author":"Y Tan","year":"2024","unstructured":"Tan Y, Zhou J, Liu K, Liu R, Zhou J, Wu Z, Li L, Zeng J, Feng X, Dong B, et al. Novel prognostic biomarkers in nasopharyngeal carcinoma unveiled by mega-data bioinformatics analysis. Front Oncol. 2024;14:1354940.","journal-title":"Front Oncol"},{"key":"5445_CR22","doi-asserted-by":"crossref","unstructured":"Zhang J, Jiang Z, Jin J, Kadeerhan G, Guo H, Wang D. Investigating the genetic links between immune cell profiles and bladder cancer: a multidisciplinary bioinformatics approach. Biomedicines. 2025. 13(5):1203.","DOI":"10.3390\/biomedicines13051203"},{"key":"5445_CR23","doi-asserted-by":"publisher","first-page":"1585727","DOI":"10.3389\/fimmu.2025.1585727","volume":"16","author":"Y Zhao","year":"2025","unstructured":"Zhao Y, Xing Z, Zhao Y, Xu H, Liu R, Yang T, Wang Y, Zhu X. Lactylation prognostic signature identifies DHCR7 as a modulator of chemoresistance and immunotherapy efficacy in bladder cancer. Front Immunol. 2025;16:1585727.","journal-title":"Front Immunol"},{"issue":"7","key":"5445_CR24","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.tem.2024.08.009","volume":"36","author":"X Wang","year":"2025","unstructured":"Wang X, Zhang S, Xue D, Neculai D, Zhang J. Metabolic reprogramming of macrophages in cancer therapy. Trends Endocrinol Metab. 2025;36(7):660\u201376.","journal-title":"Trends Endocrinol Metab"},{"issue":"1","key":"5445_CR25","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13045-024-01527-8","volume":"17","author":"J Lin","year":"2024","unstructured":"Lin J, Rao D, Zhang M, Gao Q. Metabolic reprogramming in the tumor microenvironment of liver cancer. J Hematol Oncol. 2024;17(1):6.","journal-title":"J Hematol Oncol"},{"issue":"5","key":"5445_CR26","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/j.immuni.2024.03.021","volume":"57","author":"J Xiao","year":"2024","unstructured":"Xiao J, Wang S, Chen L, Ding X, Dang Y, Han M, Zheng Y, Shen H, Wu S, Wang M, et al. 25-Hydroxycholesterol regulates lysosome AMP kinase activation and metabolic reprogramming to educate immunosuppressive macrophages. Immunity. 2024;57(5):1087\u2013e11041087.","journal-title":"Immunity"},{"key":"5445_CR27","doi-asserted-by":"publisher","first-page":"299","DOI":"10.2147\/OTT.S358008","volume":"15","author":"M Li","year":"2022","unstructured":"Li M, Che N, Jin Y, Li J, Yang W. CDKN3 Overcomes Bladder Cancer Cisplatin Resistance via LDHA-Dependent Glycolysis Reprogramming. Onco Targets Ther. 2022;15:299\u2013311.","journal-title":"Onco Targets Ther"},{"key":"5445_CR28","doi-asserted-by":"crossref","unstructured":"Chen L, Huang L, Gu Y, Cang W, Sun P, Xiang Y. Lactate-Lactylation Hands between Metabolic Reprogramming and Immunosuppression. Int J Mol Sci. 2022. 23:19.","DOI":"10.3390\/ijms231911943"},{"key":"5445_CR29","doi-asserted-by":"crossref","unstructured":"Scholtes MP, de Jong FC, Zuiverloon TCM, Theodorescu D. Role of bladder cancer metabolic reprogramming in the effectiveness of immunotherapy. Cancers (Basel) 2021. 13: 2.","DOI":"10.3390\/cancers13020288"},{"issue":"1","key":"5445_CR30","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1186\/s13046-025-03487-4","volume":"44","author":"T Li","year":"2025","unstructured":"Li T, Zhu K, Tong H, Sun Y, Zhu J, Qin Z, Chen J, Wu L, Zhang X, Wang A, et al. Cancer-associated fibroblast derived CXCL14 drives cisplatin chemoresistance by enhancing nucleotide excision repair in bladder cancer. J Exp Clin Cancer Res. 2025;44(1):265.","journal-title":"J Exp Clin Cancer Res"},{"key":"5445_CR31","doi-asserted-by":"publisher","first-page":"1580986","DOI":"10.3389\/fimmu.2025.1580986","volume":"16","author":"Z Zhou","year":"2025","unstructured":"Zhou Z, Chen Y, Wang Z, Yang S, Li Z, Shi R, Wang R, Liu K, Tang X, Li Q, et al. Characterization of cancer-related fibroblasts in bladder cancer and construction of CAFs-based bladder cancer classification: insights from single-cell and multi-omics analysis. Front Immunol. 2025;16:1580986.","journal-title":"Front Immunol"},{"key":"5445_CR32","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.cancergen.2024.12.004","volume":"290\u2013291","author":"H Liao","year":"2025","unstructured":"Liao H, Ma Q, Chen L, Guo W, Feng K, Bao Y, Zhang Y, Shen W, Huang T, Cai YD. Machine learning analysis of CD4\u2009+\u2009T cell gene expression in diverse diseases: insights from cancer, metabolic, respiratory, and digestive disorders. Cancer Genet. 2025;290\u2013291:56\u201360.","journal-title":"Cancer Genet"},{"issue":"1","key":"5445_CR33","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.cmet.2019.11.010","volume":"31","author":"MT Snaebjornsson","year":"2020","unstructured":"Snaebjornsson MT, Janaki-Raman S, Schulze A. Greasing the Wheels of the Cancer Machine: The Role of Lipid Metabolism in Cancer. Cell Metab. 2020;31(1):62\u201376.","journal-title":"Cell Metab"},{"issue":"3","key":"5445_CR34","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s10549-023-06990-4","volume":"200","author":"J Zhang","year":"2023","unstructured":"Zhang J, Miki Y, Iwabuchi E, Xu J, Kanai A, Sagara Y, Ohi Y, Rai Y, Yamaguchi R, Tanaka M, et al. Induction of SGK1 via glucocorticoid-influenced clinical outcome of triple-negative breast cancer patients. Breast Cancer Res Treat. 2023;200(3):323\u201335.","journal-title":"Breast Cancer Res Treat"},{"key":"5445_CR35","doi-asserted-by":"crossref","unstructured":"Prabhu JS, Patil S, Rajarajan S, Ce A, Nair M, Alexander A, Ramesh R, Bs S, Sridhar T. Triple-negative breast cancers with expression of glucocorticoid receptor in immune cells show better prognosis. Ann Oncol. 2021. 32(Suppl 2):S35.","DOI":"10.1016\/j.annonc.2021.03.052"},{"key":"5445_CR36","doi-asserted-by":"crossref","unstructured":"Dwyer AR, Perez Kerkvliet C, Truong TH, Hagen KM, Krutilina RI, Parke DN, Oakley RH, Liddle C, Cidlowski JA, Seagroves TN et al. Glucocorticoid receptors drive breast cancer cell migration and metabolic reprogramming via PDK4. Endocrinol. 2023. 164:7.","DOI":"10.1210\/endocr\/bqad083"},{"issue":"14","key":"5445_CR37","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.2174\/1871530323666230418113852","volume":"23","author":"H Zhang","year":"2023","unstructured":"Zhang H, Wang W, Wu Z, Zheng Y, Li X, Han S, Wang J, Zhang C. Effect of Notch Signal Pathway on Steroid Synthesis Enzymes in TM3 Cells. Endocr Metab Immune Disord Drug Targets. 2023;23(14):1771\u20139.","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"5445_CR38","doi-asserted-by":"publisher","first-page":"115969","DOI":"10.1016\/j.taap.2022.115969","volume":"441","author":"J Sun","year":"2022","unstructured":"Sun J, Xu W, Zheng S, Lv C, Lin J, Chen S, Qiu Y, Jiang X, Draz E, Wang S. Icariin promotes mouse Leydig cell testosterone synthesis via the Esr1\/Src\/Akt\/Creb\/Sf-1 pathway. Toxicol Appl Pharmacol. 2022;441:115969.","journal-title":"Toxicol Appl Pharmacol"},{"issue":"4","key":"5445_CR39","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1158\/1078-0432.CCR-17-2006","volume":"24","author":"Y Yang","year":"2018","unstructured":"Yang Y, Bai Y, He Y, Zhao Y, Chen J, Ma L, Pan Y, Hinten M, Zhang J, Karnes RJ, et al. PTEN Loss Promotes Intratumoral Androgen Synthesis and Tumor Microenvironment Remodeling via Aberrant Activation of RUNX2 in Castration-Resistant Prostate Cancer. Clin Cancer Res. 2018;24(4):834\u201346.","journal-title":"Clin Cancer Res"},{"key":"5445_CR40","doi-asserted-by":"publisher","first-page":"109738","DOI":"10.1016\/j.abb.2023.109738","volume":"747","author":"K Ma","year":"2023","unstructured":"Ma K, Liu JF, Zheng ZR, Li HY, Hu B, Meng Y. The polarization of M2 macrophages can be adjusted to alleviate renal injury by methylprednisolone in sepsis-AKI. Arch Biochem Biophys. 2023;747:109738.","journal-title":"Arch Biochem Biophys"},{"key":"5445_CR41","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.actbio.2022.08.054","volume":"152","author":"Y Li","year":"2022","unstructured":"Li Y, Liang Q, Zhou L, Cao Y, Yang J, Li J, Liu J, Bi J, Liu Y. An ROS-responsive artesunate prodrug nanosystem co-delivers dexamethasone for rheumatoid arthritis treatment through the HIF-1\u03b1\/NF-\u03baB cascade regulation of ROS scavenging and macrophage repolarization. Acta Biomater. 2022;152:406\u201324.","journal-title":"Acta Biomater"},{"issue":"17","key":"5445_CR42","doi-asserted-by":"publisher","first-page":"4713","DOI":"10.1016\/j.cell.2024.06.012","volume":"187","author":"J Yu","year":"2024","unstructured":"Yu J, Yan Y, Li S, Xu Y, Parolia A, Rizvi S, Wang W, Zhai Y, Xiao R, Li X, et al. Progestogen-driven B7-H4 contributes to onco-fetal immune tolerance. Cell. 2024;187(17):4713\u2013e47324719.","journal-title":"Cell"},{"key":"5445_CR43","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.cancergen.2025.08.010","volume":"298\u2013299","author":"S Ubaid","year":"2025","unstructured":"Ubaid S, Kushwaha R, Kashif M, Singh V. Comprehensive analysis of oncogenic determinants across tumor types via multi-omics integration. Cancer Genet. 2025;298\u2013299:44\u201362.","journal-title":"Cancer Genet"},{"key":"5445_CR44","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.cancergen.2025.03.004","volume":"294\u2013295","author":"S Narote","year":"2025","unstructured":"Narote S, Desai SA, Patel VP, Deshmukh R, Raut N, Dapse S. Identification of new immune target and signaling for cancer immunotherapy. Cancer Genet. 2025;294\u2013295:57\u201375.","journal-title":"Cancer Genet"},{"key":"5445_CR45","doi-asserted-by":"publisher","first-page":"115743","DOI":"10.1016\/j.intimp.2025.115743","volume":"167","author":"Y Tan","year":"2025","unstructured":"Tan Y, Zhou J, Liu K, Wu Z, Liu R, Zhou J, Li Y, Zhao Y, Ma X, Zhou G, et al. Malignant cell-mediated Treg immune suppression via ICOSLG-ICOS axis in tumor microenvironment relates to nasopharyngeal carcinoma prognosis. Int Immunopharmacol. 2025;167:115743.","journal-title":"Int Immunopharmacol"},{"issue":"14","key":"5445_CR46","doi-asserted-by":"publisher","first-page":"5459","DOI":"10.7150\/ijbs.74546","volume":"18","author":"L Shen","year":"2022","unstructured":"Shen L, Zhang J, Zheng Z, Yang F, Liu S, Wu Y, Chen Y, Xu T, Mao S, Yan Y, et al. PHGDH Inhibits Ferroptosis and Promotes Malignant Progression by Upregulating SLC7A11 in Bladder Cancer. Int J Biol Sci. 2022;18(14):5459\u201374.","journal-title":"Int J Biol Sci"},{"issue":"9","key":"5445_CR47","doi-asserted-by":"publisher","first-page":"6700","DOI":"10.3390\/curroncol29090526","volume":"29","author":"R Yadollahvandmiandoab","year":"2022","unstructured":"Yadollahvandmiandoab R, Jalalizadeh M, Buosi K, Garcia-Perdomo HA, Reis LO. Immunogenic Cell Death Role in Urothelial Cancer Therapy. Curr Oncol. 2022;29(9):6700\u201313.","journal-title":"Curr Oncol"},{"key":"5445_CR48","doi-asserted-by":"publisher","first-page":"101584","DOI":"10.1016\/j.mtbio.2025.101584","volume":"31","author":"Y Shi","year":"2025","unstructured":"Shi Y, Fan G, Yang E, Zhang Y, Ding H, Tian J, Cheng L, Wang H, Hao T, Wang B, et al. Enhanced efficacy of immune checkpoint inhibitors by folate-targeted multifunctional drug through synergistic therapy inducing ferroptosis and immunogenic cell death in bladder cancer. Mater Today Bio. 2025;31:101584.","journal-title":"Mater Today Bio"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-05445-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05445-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05445-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T03:07:33Z","timestamp":1789096053000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-026-05445-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,17]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5445"],"URL":"https:\/\/doi.org\/10.1007\/s12672-026-05445-8","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,17]]},"assertion":[{"value":"26 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1324"}}